• TRM (USD/COP)COP 3,235.59 +1.65% +COP 52.60Colombia's official exchange rate (Financial Superintendence), valid Nov 4 to Nov 4
  • EuroCOP 3,617.08 +1.72% +COP 61.02Reference: TRM crossed with the European Central Bank rate of Nov 3; not the market quote
  • Mexican pesoCOP 173.98 +3.35% +COP 5.64Reference: TRM crossed with the European Central Bank rate of Nov 3; not the market quote

China weighs banning foreign acquisitions of critical biopharma platforms

FinanceInternationalFierceBiotech15 s readAI summary
Image: FierceBiotech

China is preparing a draft policy to restrict foreign investors' acquisition of critical biopharma platforms, according to Fierce Biotech. The move comes as Washington steps up efforts to tighten cross-border life sciences deals involving Chinese assets. Beijing is seeking to strengthen its grip on biomedical innovation.

Read the full story at FierceBiotech

IASummary generated by artificial intelligence from a story by FierceBiotech. It may contain errors: the original source prevails.

More flashes